Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C26H37N5O2 |
Molecular Weight | 451.6043 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC3=CNC4=C3C(=CC=C4)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
InChI
InChIKey=KORNTPPJEAJQIU-KJXAQDMKSA-N
InChI=1S/C26H37N5O2/c1-5-11-30-17-19(25(32)31(26(33)27-6-2)13-8-12-29(3)4)14-21-20-9-7-10-22-24(20)18(16-28-22)15-23(21)30/h5,7,9-10,16,19,21,23,28H,1,6,8,11-15,17H2,2-4H3,(H,27,33)/t19-,21-,23-/m1/s1
Molecular Formula | C26H37N5O2 |
Molecular Weight | 451.6043 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:22:08 UTC 2023
by
admin
on
Sat Dec 16 16:22:08 UTC 2023
|
Record UNII |
LL60K9J05T
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C66884
Created by
admin on Sat Dec 16 16:22:10 UTC 2023 , Edited by admin on Sat Dec 16 16:22:10 UTC 2023
|
||
|
NCI_THESAURUS |
C38149
Created by
admin on Sat Dec 16 16:22:10 UTC 2023 , Edited by admin on Sat Dec 16 16:22:10 UTC 2023
|
||
|
WHO-VATC |
QG02CB03
Created by
admin on Sat Dec 16 16:22:10 UTC 2023 , Edited by admin on Sat Dec 16 16:22:10 UTC 2023
|
||
|
WHO-ATC |
N04BC06
Created by
admin on Sat Dec 16 16:22:10 UTC 2023 , Edited by admin on Sat Dec 16 16:22:10 UTC 2023
|
||
|
NDF-RT |
N0000007618
Created by
admin on Sat Dec 16 16:22:10 UTC 2023 , Edited by admin on Sat Dec 16 16:22:10 UTC 2023
|
||
|
LIVERTOX |
135
Created by
admin on Sat Dec 16 16:22:10 UTC 2023 , Edited by admin on Sat Dec 16 16:22:10 UTC 2023
|
||
|
WHO-VATC |
QN04BC06
Created by
admin on Sat Dec 16 16:22:10 UTC 2023 , Edited by admin on Sat Dec 16 16:22:10 UTC 2023
|
||
|
NDF-RT |
N0000175827
Created by
admin on Sat Dec 16 16:22:10 UTC 2023 , Edited by admin on Sat Dec 16 16:22:10 UTC 2023
|
||
|
WHO-ATC |
G02CB03
Created by
admin on Sat Dec 16 16:22:10 UTC 2023 , Edited by admin on Sat Dec 16 16:22:10 UTC 2023
|
||
|
NDF-RT |
N0000007618
Created by
admin on Sat Dec 16 16:22:10 UTC 2023 , Edited by admin on Sat Dec 16 16:22:10 UTC 2023
|
||
|
EMA VETERINARY ASSESSMENT REPORTS |
VELACTIS [SUSPENDED]
Created by
admin on Sat Dec 16 16:22:10 UTC 2023 , Edited by admin on Sat Dec 16 16:22:10 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL1201087
Created by
admin on Sat Dec 16 16:22:10 UTC 2023 , Edited by admin on Sat Dec 16 16:22:10 UTC 2023
|
PRIMARY | |||
|
460
Created by
admin on Sat Dec 16 16:22:10 UTC 2023 , Edited by admin on Sat Dec 16 16:22:10 UTC 2023
|
PRIMARY | |||
|
C047047
Created by
admin on Sat Dec 16 16:22:10 UTC 2023 , Edited by admin on Sat Dec 16 16:22:10 UTC 2023
|
PRIMARY | |||
|
CABERGOLINE
Created by
admin on Sat Dec 16 16:22:10 UTC 2023 , Edited by admin on Sat Dec 16 16:22:10 UTC 2023
|
PRIMARY | |||
|
81409-90-7
Created by
admin on Sat Dec 16 16:22:10 UTC 2023 , Edited by admin on Sat Dec 16 16:22:10 UTC 2023
|
PRIMARY | |||
|
37
Created by
admin on Sat Dec 16 16:22:10 UTC 2023 , Edited by admin on Sat Dec 16 16:22:10 UTC 2023
|
PRIMARY | |||
|
C47428
Created by
admin on Sat Dec 16 16:22:10 UTC 2023 , Edited by admin on Sat Dec 16 16:22:10 UTC 2023
|
PRIMARY | |||
|
5860
Created by
admin on Sat Dec 16 16:22:10 UTC 2023 , Edited by admin on Sat Dec 16 16:22:10 UTC 2023
|
PRIMARY | |||
|
100000092143
Created by
admin on Sat Dec 16 16:22:10 UTC 2023 , Edited by admin on Sat Dec 16 16:22:10 UTC 2023
|
PRIMARY | |||
|
II-10
Created by
admin on Sat Dec 16 16:22:10 UTC 2023 , Edited by admin on Sat Dec 16 16:22:10 UTC 2023
|
PRIMARY | |||
|
DTXSID6022719
Created by
admin on Sat Dec 16 16:22:10 UTC 2023 , Edited by admin on Sat Dec 16 16:22:10 UTC 2023
|
PRIMARY | |||
|
47579
Created by
admin on Sat Dec 16 16:22:10 UTC 2023 , Edited by admin on Sat Dec 16 16:22:10 UTC 2023
|
PRIMARY | RxNorm | ||
|
3286
Created by
admin on Sat Dec 16 16:22:10 UTC 2023 , Edited by admin on Sat Dec 16 16:22:10 UTC 2023
|
PRIMARY | |||
|
1084306
Created by
admin on Sat Dec 16 16:22:10 UTC 2023 , Edited by admin on Sat Dec 16 16:22:10 UTC 2023
|
PRIMARY | |||
|
54746
Created by
admin on Sat Dec 16 16:22:10 UTC 2023 , Edited by admin on Sat Dec 16 16:22:10 UTC 2023
|
PRIMARY | |||
|
Cabergoline
Created by
admin on Sat Dec 16 16:22:10 UTC 2023 , Edited by admin on Sat Dec 16 16:22:10 UTC 2023
|
PRIMARY | |||
|
SUB06041MIG
Created by
admin on Sat Dec 16 16:22:10 UTC 2023 , Edited by admin on Sat Dec 16 16:22:10 UTC 2023
|
PRIMARY | |||
|
DB00248
Created by
admin on Sat Dec 16 16:22:10 UTC 2023 , Edited by admin on Sat Dec 16 16:22:10 UTC 2023
|
PRIMARY | |||
|
LL60K9J05T
Created by
admin on Sat Dec 16 16:22:10 UTC 2023 , Edited by admin on Sat Dec 16 16:22:10 UTC 2023
|
PRIMARY | |||
|
LL60K9J05T
Created by
admin on Sat Dec 16 16:22:10 UTC 2023 , Edited by admin on Sat Dec 16 16:22:10 UTC 2023
|
PRIMARY | |||
|
m2876
Created by
admin on Sat Dec 16 16:22:10 UTC 2023 , Edited by admin on Sat Dec 16 16:22:10 UTC 2023
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
BINDER->LIGAND |
BINDING
|
||
|
TARGET -> AGONIST | |||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
EP
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
7% in urine
MINOR
URINE
|
||
|
METABOLITE -> PARENT |
41% in urine
MAJOR
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||